Aurora builds on a decade of global leadership in plant genetics with the launch of occo

Genetics and licensing  business will be led by new hire, casey whelan, vp, genetics business development edmonton, ab, nov. 16, 2021 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora") (nasdaq: acb) (tsx: acb), the canadian company defining the future of cannabinoids worldwide, today announced the naming of the company's new genetics licensing business unit – occo – a leading innovator in the scientific discovery and commercial advancement of novel cannabis cultivars, backed by aurora's state-of-the-art breeding and genetics facility in comox, british columbia. occo, derived from the latin word for 'tilling of the field,' refers to the brand's reverence for the cannabis plant, and its mission to support the people who grow and consume it.
ACB Ratings Summary
ACB Quant Ranking